Effect of diet therapy in treatment of polycystic ovary syndrome

Not Applicable

Conditions: Polycystic ovary syndrome.
Sclerocystic ovary syndrome Stein-Leventhal syndrome
E28.2

Registration Number: IRCT201304235623N6

Lead Sponsor: Kashan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 108

Inclusion Criteria

Women aged 18-40 years
Diagnosed with PCOS

Exclusion Criteria

Individuals with neoplastic
Cardiovascular disorders
Malabsorptive disorders
Current or previous (within the last 6 months) use of hormonal
Antidiabetic medications
Anti-obesity medications

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DL-Cholesterol. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;Hs-CRP. Timepoint: Baseline and End-of-trial. Method of measurement: Elisa.

Secondary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Total antioxidant capacity. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.;. Timepoint: . Method of measurement: .;Glutathione. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.